Unknown

Dataset Information

0

First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease.


ABSTRACT: Recently, the direct thrombin (thr) inhibitor dabigatran has proven to be beneficial in animal models of Alzheimer's disease (AD). Aiming at discovering novel multimodal agents addressing thr and AD-related targets, a selection of previously and newly synthesized potent thr and factor Xa (fXa) inhibitors were virtually screened by the Multi-fingerprint Similarity Searching aLgorithm (MuSSeL) web server. The N-phenyl-1-(pyridin-4-yl)piperidine-4-carboxamide derivative 1, which has already been experimentally shown to inhibit thr with a Ki value of 6 nM, has been flagged by a new, upcoming release of MuSSeL as a binder of cholinesterase (ChE) isoforms (acetyl- and butyrylcholinesterase, AChE and BChE), as well as thr, fXa, and other enzymes and receptors. Interestingly, the inhibition potency of 1 was predicted by the MuSSeL platform to fall within the low-to-submicromolar range and this was confirmed by experimental Ki values, which were found equal to 0.058 and 6.95 μM for eeAChE and eqBChE, respectively. Thirty analogs of 1 were then assayed as inhibitors of thr, fXa, AChE, and BChE to increase our knowledge of their structure-activity relationships, while the molecular determinants responsible for the multiple activities towards the target enzymes were rationally investigated by molecular cross-docking screening.

SUBMITTER: Purgatorio R 

PROVIDER: S-EPMC8434007 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6542289 | biostudies-literature
| S-EPMC10366214 | biostudies-literature
| S-EPMC6150311 | biostudies-literature
| S-EPMC7659976 | biostudies-literature
| S-EPMC8953944 | biostudies-literature
| S-EPMC5833662 | biostudies-literature
| S-EPMC5924788 | biostudies-literature
| S-EPMC4025825 | biostudies-literature
| S-EPMC9521886 | biostudies-literature
| S-EPMC10476022 | biostudies-literature